...
首页> 外文期刊>Applied Microbiology and Biotechnology >Engineering cell physiology to enhance recombinant protein production in Escherichia coli
【24h】

Engineering cell physiology to enhance recombinant protein production in Escherichia coli

机译:工程细胞生理学,以增强大肠杆菌中重组蛋白的产生

获取原文
获取原文并翻译 | 示例

摘要

The advent of recombinant DNA technology has revolutionized the strategies for protein production. Due to the well-characterized genome and a variety of mature tools available for genetic manipulation, Escherichia coli is still the most common workhorse for recombinant protein production. However, the culture for industrial applications often presents E. coli cells with a growth condition that is significantly different from their natural inhabiting environment in the gastrointestinal tract, resulting in deterioration in cell physiology and limitation in cell’s productivity. It has been recognized that innovative design of genetically engineered strains can highly increase the bioprocess yield with minimum investment on the capital and operating costs. Nevertheless, most of these genetic manipulations, by which traits are implanted into the workhorse through recombinant DNA technology, for enhancing recombinant protein productivity often translate into the challenges that deteriorate cell physiology or even jeopardize cell survival. An in-depth understanding of these challenges and their corresponding cellular response at the molecular level becomes crucial for developing superior strains that are more physiologically adaptive to the production environment to improve culture productivity. With the accumulated knowledge in cell physiology, whose importance to gene overexpression was to some extent undervalued previously, this review is intended to focus on the recent biotechnological advancement in engineering cell physiology to enhance recombinant protein production in E. coli.
机译:重组DNA技术的出现彻底改变了蛋白质生产策略。由于基因组的特征明确,以及可用于基因操作的各种成熟工具,大肠杆菌仍然是重组蛋白生产中最常见的主力。但是,用于工业应用的培养物通常使大肠杆菌细胞的生长条件与它们在胃肠道中的自然居住环境明显不同,从而导致细胞生理状况恶化和细胞生产力受到限制。已经认识到,基因工程菌株的创新设计可以以最少的资本和运营成本投资来大大提高生物工艺产量。然而,大多数通过重组DNA技术将特征植入主力的遗传操作,以提高重组蛋白的生产力,通常会转化为挑战,破坏细胞生理甚至威胁细胞存活。对这些挑战及其在分子水平上相应的细胞反应的深入了解对于开发在生理上更适应生产环境以提高培养生产力的优良菌株至关重要。凭借在细胞生理学方面积累的知识(以前对基因过表达的重要性在一定程度上被低估了),本综述旨在关注工程细胞生理学中最近的生物技术进展,以增强大肠杆菌中的重组蛋白生产。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号